Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
DRKS00020511Phase 2Recruiting
- Sponsor
- IntraBio
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 4
01
Overview
Phase 2, open-label, single-arm trial of trenonacog alfa in ataxia-telangiectasia (AT), sponsored by IntraBio. Started Jun 2020; status: recruiting.
02
Drugs
trenonacog alfa
03
Conditions
ataxia-telangiectasia (AT)
Beyond the preview
Go deeper on DRKS00020511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00020511.